Try a new search

Format these results:

Searched for:

in-biosketch:yes

person:silvej03

Total Results:

176


Traumatic brain injury

Chapter by: Silver, JM; Yudofsky, SC; Hales, RE
in: Model psychopharmacology curriculum : for training directors and teachers of psychopharmacology in psychiatric residency programs by Glick, Ira D [Eds]
[S.l.] : American Society of Clinical Psychopharmacology, c2008
pp. ?-?
ISBN: n/a
CID: 427172

Stimulants and acetylcholinesterase inhibitors for the treatment of cognitive impairment after traumatic brain injury

Arciniegas, DB; Silver, JM; McAllister, TW
ORIGINAL:0008330
ISSN: 1936-9255
CID: 426762

Neuropsychiatric aspects of traumatic brain injury

Chapter by: Silver, Jonathan M; Hales, Robert E; Yudofsky, Stuart C
in: The American Psychiatric Publishing textbook of neuropsychiatry and behavioral neurosciences by Yudofsky, Stuart C [Eds]
Arlington, VA, US: American Psychiatric Publishing, Inc., 2008
pp. 595-647
ISBN: 978-1-58562-239-9
CID: 4928

Characterizing 'mild' in traumatic brain injury with proton MR spectroscopy in the thalamus: Initial findings

Kirov, Ivan; Fleysher, Lazar; Babb, James S; Silver, Jonathan M; Grossman, Robert I; Gonen, Oded
OBJECTIVE: Although most mild traumatic brain injury (mTBI) patients suffer any of several post-concussion symptoms suggestive of thalamic involvement, they rarely present with any MRI-visible pathology. The aim here, therefore, is to characterize their thalamic metabolite levels with proton MR spectroscopy (1H-MRS) compared with healthy controls. METHODS: T1-weighted MRI and multi-voxel 1H-MRS were acquired at 3 Tesla from 20 mTBI (Glasgow Coma Scale score of 15-13) patients, 19-59 years old, 0-7 years post-injury; and from 17 age and gender matched healthy controls. Mixed model regression was used to compare patients and controls with respect to the mean absolute N-acetylaspartate (NAA), choline (Cho) and creatine (Cr) levels within each thalamus. RESULTS: The mTBI-induced thalamic metabolite concentration changes were under +/- 13.0% for NAA, +/- 13.5% for Cr and +/- 18.8% for Cho relative to their corresponding concentrations in the controls: NAA: 10.08 +/- 0.30 (mean +/- standard error), Cr: 5.62 +/- 0.18 and Cho: 2.08 +/- 0.09 mM. These limits represent the minimal detectable differences between the two cohorts. CONCLUSION: The change in metabolic levels in the thalamus of patients who sustained clinically defined mTBI could be an instrumental characteristic of 'mildness'. 1H-MRS could, therefore, serve as an objective laboratory indicator for differentiating 'mild' from more severe categories of head-trauma, regardless of the presence or lack of current clinical symptoms
PMID: 17882630
ISSN: 0269-9052
CID: 93791

Agitation and aggression

Chapter by: Silver, Jonathan M; Yudofsky, Stuart C; Anderson, Karen E
in: Guide to neuropsychiatric therapeutics by Coffey, C. Edward [Eds]
Philadelphia, PA, US: Lippincott Williams & Wilkins Publishers, 2007
pp. 371-387
ISBN: 0-7817-9935-x
CID: 4686

Unexplained neuropsychiatric symptoms

Chapter by: Ovsiew, Fred; Silver, Jonathan M
in: Guide to neuropsychiatric therapeutics by Coffey, C. Edward [Eds]
Philadelphia, PA, US: Lippincott Williams & Wilkins Publishers, 2007
pp. 335-347
ISBN: 0-7817-9935-x
CID: 4687

Guide to neuropsychiatric therapeutics

Coffey, C. Edward; McAllister, Thomas W; Silver, Jonathan M
Philadelphia PA : Lippincott Williams & Wilkins, 2007
Extent: xiii, 449
ISBN: 0-7817-9935-x
CID: 1443

Pharmacotherapy of Cognitive Impairment

Chapter by: Arciniegas, DB; Silver, JM
in: Brain injury medicine : principles and practice by Zasler, Nathan D.; Katz, Douglas I; Zafonte, Ross D [Eds]
New York : Demos, c2007
pp. 995-1022
ISBN: 9781888799934
CID: 427162

Pharmacotherapy of Neuropsychiatric Disturbances

Chapter by: Silver, JM; Arciniegas, DB
in: Brain injury medicine : principles and practice by Zasler, Nathan D.; Katz, Douglas I; Zafonte, Ross D [Eds]
New York : Demos, c2007
pp. 963-994
ISBN: 9781888799934
CID: 427152

Diagnosis and management of pathological laughter and crying

Parvizi, Josef; Arciniegas, David B; Bernardini, Gary L; Hoffmann, Michael W; Mohr, Jay P; Rapoport, Mark J; Schmahmann, Jeremy D; Silver, Jonathan M; Tuhrim, Stanley
Patients with various neurologic disorders exhibit exaggerated or inappropriate episodes of laughter, crying, or both without an apparent motivating stimulus or in response to stimuli that would not have elicited such an emotional response before the onset of the underlying disease. During these episodes, patients have difficulty controlling their emotional expression according to the contextual information. In contrast, patients with mood disorders have a pervasive and sustained change in their emotional experience and thus exhibit spells of laughter or crying because of an underlying mania or depression. This article focuses on the clinical presentation, diagnosis, prevalence, and proposed pathophysiological mechanisms of and available treatment options for this clinical phenomenon.
PMID: 17120404
ISSN: 0025-6196
CID: 426282